CGNAX
Price
$21.75
Change
-$0.07 (-0.32%)
Updated
Oct 16 closing price
Net Assets
21.43B
CVTCX
Price
$55.64
Change
-$0.43 (-0.77%)
Updated
Oct 16 closing price
Net Assets
3.21B
Interact to see
Advertisement

CGNAX vs CVTCX

Header iconCGNAX vs CVTCX Comparison
Open Charts CGNAX vs CVTCXBanner chart's image
American Funds Growth and Inc Port 529A
Price$21.75
Change-$0.07 (-0.32%)
VolumeN/A
Net Assets21.43B
Calamos Growth & Income C
Price$55.64
Change-$0.43 (-0.77%)
VolumeN/A
Net Assets3.21B
CGNAX vs CVTCX Comparison Chart in %
View a ticker or compare two or three
VS
CGNAX vs. CVTCX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGNAX is a Hold and CVTCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CGNAX has more cash in the bank: 21.4B vs. CVTCX (3.21B). CGNAX pays higher dividends than CVTCX: CGNAX (1.58) vs CVTCX (0.24). CGNAX was incepted earlier than CVTCX: CGNAX (13 years) vs CVTCX (29 years). CVTCX (1.80) is less costly to investors than CGNAX (0.69). CVTCX is a more actively managed with annual turnover of: 28.00 vs. CGNAX (10.00). CGNAX has a lower initial minimum investment than CVTCX: CGNAX (250) vs CVTCX (2500). CVTCX annual gain was more profitable for investors over the last year : 12.22 vs. CGNAX (10.82). CVTCX (45.82) and CGNAX (44.75) have equivalent 5 years return.
CGNAXCVTCXCGNAX / CVTCX
Total Expense Ratio0.691.8038%
Annual Report Gross Expense Ratio0.691.8038%
Fund Existence13 years29 years-
Gain YTD15.35915.039102%
Front Load4%N/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets21.4B3.21B667%
Annual Yield % from dividends1.580.24648%
Returns for 1 year10.8212.2288%
Returns for 3 years55.3652.45106%
Returns for 5 years44.7545.8298%
Returns for 10 years95.0890.37105%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMCCX6.93N/A
N/A
Voya MidCap Opportunities C
EMEAX14.22N/A
N/A
Ashmore Emerging Markets Equity A
TEQPX13.99N/A
N/A
Nuveen Emerging Markets Eq Idx Prem
VKSRX20.17N/A
N/A
Virtus KAR Small-Mid Cap Core R6
LYFIX14.64N/A
N/A
AlphaCentric Life Sciences & Hlthcare I